michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, Stan, this is Tyler. No, we're seeing steady momentum. I mean, we have some seasonality in our business, specifically in the mid-market and enterprise business. And from that, that's where we do track pipe obviously, and it's solid, you know, globally right now.
But, you know, our presence is mainly in North America and Europe, and that's where we have our field reps out there. As a reminder, you know, we also have this product-led growth inbound motion. And that's not really something you consider in pipe. It's more about how many customers are in trial, and those trials typically convert, you know, less than 30 days.
And so, we're tracking both, obviously, to be able to get a sense of it, and growth is good. It's solid.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Tracy.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Of course.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So 2020's international subscriptions, we ended 2020 at about 335. And we ended 2013 in the North America efforts. If you go all the way back to 2013, we ended 2013 at about 370. And in 2014, in North America, we ended at 730. And so we've put a forecast together this year that we'll start at 335, so a little bit less than we started in 2013 in North America. But we'll take that to 835 internationally in kind of our first year, which is obviously better than the 730. So put another way, we do see a faster adoption rate with the International customer base. And International for us isn't just scil. So part of that 330 has been work before we really got busy with scil. So CVM companies in Spain. We've since put those two businesses together with scil business and the CVM business. So they've been active in subscriptions during the second half, and they've done well. And then Australia has done well also. So that 330, I view, is largely a baseline number. That's kind of our starting number, that 335. And I view that as very similar to the 370 that we started in North America in 2017. But I do think it's going to be a faster adoption rate. So we're calling out 835 for this year, which is faster than what we did in North America.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Barb?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We have the letter of credit which was the security in some deposits, but this is -- I mean, Senior Lifestyle has been cooperative in this process, facilitating the transitions, the sales and that's our general understanding of how this would be unwound, and the economics where that would reside and to the extent there is positive cash flow from operations or from additional stimulus funds, but those funds would come to LTC.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, I will start with that one. We were very, very pleased again to see the IFT growth return. The residential piece of the business within flow continues to be strong. The recovery in commercial has also helped the flow business. And then within industrial, food and beverage has been a nice growth area for us. So it continues to grow to be able to guide for the full year low double digit growth for us is exciting after the challenging year last year. And we expect the momentum to continue as well in IFT.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. Morning and afternoon. Thank you. Look, most of my near-term questions have been asked.
So just given there's been lots of reference to high-flow therapy today, I guess, it would be remiss of me not to just ask you guys for a bit more of a sort of comprehensive update on where you're positioned and what your strategy is there? I mean, do you guys have what you need in terms of current portfolio? Or are there some areas that might make sense from a sort of tuck-in perspective? And just generally, I guess, your views on market growth? And how you fit within that over the quarters and years ahead? I mean, the references you made today are indicative clearly of how increasingly important this therapy looks in various respiratory markets but that just be keen to get some sense of quantification from you if that would be possible. Thank you.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Regarding synergy, it's -- e-mobility is everywhere. So, when we joined this partnership, the TOGG partnership, everyone was thinking that why telco operator joining this EV consortium. But everybody right now, since that e-mobility is trend, the connectivity, entertainment and the car without driver is very important, which needs high speed, low latency and strong customer engagement. So that's the main reason that we have synergies. So Turkcell and TOGG can have lasting together, including smart-living solution in smart city, smart charging, data-based business model, suppliers and partners with no competencies and so on. There are integrated digital services and payment. Payment is very important as well, charging solution and infrastructure, IoT is there. So, there are many, many things may come during the road map, but we'll see what we can help on this side. But I think clearly, Turkcell has vision to finalize this synergy.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So why don't you take that one, Tom.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, good morning. Thanks for taking our questions. I also wanted to touch a little bit on general merchandise. So with -- in the US, so with low 20% growth, just curious if you think you gained market share there. We were thinking maybe 26% market growth, which is rough estimate. But just curious how you're thinking about that, how you measure that and also how your efforts with Walmart fulfillment services and third-party are maybe contributing to your general merchandise growth.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. So, I would say -- sure, for I-45 this quarter, I think I would tell you that the repayments that came in, which were plentiful, came in early during the quarter. And then, the originations, honestly, that we've actually closed but haven't even settled. So, you know, the settlement process for some of these credits takes a bit of time.
So, we're looking probably at, you know, I think, $15 million to $20 million of originations that we'll probably settle in this June quarter. So, I think, just a bit of a mismatch, right, for -- in terms of the activity to the dividend. So, to your second question, we do expect there to be a bounce-back in this following quarter.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Well, we obviously, we believe our back in a range of, call it, four times in terms of leverage. And we feel that that's a much more comfortable place for the company to operate and with improving cash flow, it gives us other opportunities. We may take that down a little bit here and there as we need to across the international operations. But obviously, with the growth in cash too, we can do other things with -- obviously, keep that cash in play or use that for further investments in the business as we move forward. So with $400 million being a pretty stable capital, that's going to be there for a while, obviously. There's -- again, we have a lot more flexibility.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks Julien.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It is. It's about $2.5 million a year. But of course, there are some offsetting increases, right? Each of these other contracts have escalators, and we have some added functionalities. So you won't see the entire $2.5 million as a straight reduction.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. In terms of uptake --

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, yeah, we're excited about our consumer business. As you know, we've consolidated our former MPS business with our consumer business, our food and beverage business. And that's really exciting, just again, from the efficiencies on the back end, but also the growth we can bring pulling those together. We're seeing retail come back, obviously, quite a bit.
And what's also really exciting about the consumer business is our ability to improve margins, which is a big focus for us. Our tie-in with the machinery business allows for really unique solutions. So we think consumer has tremendous opportunities for further growth. We're seeing that growth both in the U.S.
and in Europe. So we see this continuing as we go through the rest of the year and into 2022.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks. Good morning. My question is around credit. If you could expand upon the ReMatch protocol that you highlighted in your prepared comments and just differentiate that versus some of the other offerings you have in credit and thinking about 2021 and what has kind of the best potential do you think for uptake?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
On next year, we wouldn't comment -- we'll comment again at year-end. On inventory, we typically don't guide ahead on inventory levels.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks. Good morning. Can you relate to the income strength that you saw this quarter to the growth you're seeing in the Southeast region? Are you leading in the Southeast with your fee-based products like treasury management rather than credit as you grow into that region? And if you could discuss the longer-term growth outlook across your other fee-based products in the Southeast.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah, we do have that expectation, Dan, as electives start to get scheduled here. I know a lot were put on hold during the surge, but as those start to come back, I think it's too early to say whether home health has become a more permanent solution. Certainly, there will be those higher acuity cases that it's not a permanent solution on and maybe those are some of the majority of the electives that have been postponed because you could have a really high acuity discharge. You know it's going to be high acuity and you postpone it because you know that patient can't go to home health, that they won't recover the same. They need 24-hour care. So, I think it's too early to determine if the discharge patterns have been permanently altered. Right now, we're -- the conventional wisdom is that it will trend back to normal, pre-COVID.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey. Good morning, everyone. Shane, just a quick one right here. As best as I can tell, it seems like you're in the best position to get back to investment grade next.
Is it a stated objective of the company to get to an IG rating? Where are you on that?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi, everyone, good morning. Thanks for the details. My line drops, I apologize if you already answered this question. Howard congratulations on the performance in Consumer. When you were talking about where you're adding capital this year, you enumerated a number of projects. One area you didn't really mention was composite cans. Even though the paper can business seems like it's having a great year, why are you spending or why are you not spending behind the growth that you're seeing in composite cans? And if you are spending where are you putting it in terms of the growth outlook there?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hi. This is Swapnil on for Gena. Thanks for taking our questions. So I had a Fabry question. Since it looks like Gb3 reduction in kidney biopsies could serve as a surrogate endpoint, is it safe to assume -- like you are predominantly focused on recruiting patients with kidney defect? And do you think that FDA would require longer-term follow-up to monitor eGFR to grant a full approval, based on the Fabrazyme update? Thanks.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, listen, I mean, I can give you a qualitative overall answer. Keep in mind that we're very happy that finally, we have a global green energy company, right? I mean we have operations in many parts of the world, we have different types of products, and all of them -- they have something to get from each other. We have the Honey Badger, M-ZERO. Now, we have SerEnergy, as you say, the telecom product, and the liquid cooled system. We all talk to each other and it is our job also to integrate the groups in the right way. So, definitely there is a central direction to all of this, right. But, soon as we get new products and new capabilities and new development needs and costs, we integrate that under one umbrella. But -- that's where we're -- that's where we're now.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'm hopeful '22 will be a better year for them, just like '21 was for us. So -- but there'll be more proactive gentlemen, I say they, I mean, again, it's country by country. But in many spots, they'll be more proactive if COVID spikes. In terms of restrictions, I should say.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks for taking the question. So just, Dave, to follow up on that so I'm clear. So, you're guiding segment margin overall lower versus, I guess, whatever that, call, 11.8% midpoint for 2021, you're guiding it lower in '22? And then in terms of free cash flow on an absolute basis, is '23 and '24 free cash flow higher than 2021 transaction-adjusted free cash flow just on an absolute basis?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I don't think we'd have any comment on that, Vincent.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Morning everyone. Thank you for taking the question. Congrats on the results and Ryan, congrats on your upcoming closing tomorrow. So back on RealSure, it sounds like youre going to offer a buy product now so folks can buy with cash. I guess, just curious if you can expand a little bit on that part of the model. Is this like a buy before you sell type of product? Or what else differentiates that? How big can that be as part of the whole platform? Thank you.

    Prediction (one of UP, DOWN, SAME): DOWN